Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2020

Feb 28, 2020

29995_dirs_2020-02-27_096a5539-64ef-4aca-855b-fdeb7ab11c8c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2020-02-25

Reporting Person: Lee Esther (EVP - Gl. Chief Marketing Off.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-25 Common Stock A 9755 Acquired 39695 Direct
2020-02-25 Common Stock F 249 $47.58 Disposed 39446 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-25 Employee Stock Options (right to buy) $47.58 A 11823 Acquired 2030-02-24 Common Stock (11823.0) Direct
2020-02-25 Restricted Stock Units $ A 3941 Acquired Common Stock (3941.0) Direct

Footnotes

F1: Shares earned from the payout of 2017-2019 performance share award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. The reporting person deferred these shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such shares for a specific period of time.

F2: Shares withheld to satisfy the reporting person's tax withholding obligation due on the deferred shares.

F3: The options become exercisable in equal installments on each of the first three anniversaries of the grant date.

F4: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock.

F5: The restricted stock units vest in substantially equal installments on the first business day in March following each of the first three anniversaries of the grant date.